• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿毒症性贫血中促红细胞生成素治疗的数学模型。它能提高成本效益吗?

Mathematical modeling of erythropoietin therapy in uremic anemia. Does it improve cost-effectiveness?

作者信息

Bellazzi R, Siviero C, Bellazzi R

机构信息

Dipartimento di Informatica e Sistemistica, Università di Pavia, Italy.

出版信息

Haematologica. 1994 Mar-Apr;79(2):154-64.

PMID:8063263
Abstract

This paper describes the improvements in r-HuEPO therapy of uremic patients that may be obtained by using a mathematical model of patient response together with a delivery control strategy derived from the theory of industrial control. A mathematical model of r-HuEPO action is presented, and its applicability to dialytic patients is shown. Moreover, a new statistical technique for identifying the parameters of the mathematical model analyzing a patient population is summarized, and a control strategy for r-HuEPO delivery in uremic patients based on a Fuzzy Set Controller is introduced. Some results obtained from simulation, are presented.

摘要

本文描述了通过使用患者反应的数学模型以及源自工业控制理论的给药控制策略,在尿毒症患者的重组人促红细胞生成素(r-HuEPO)治疗中可能实现的改进。文中给出了r-HuEPO作用的数学模型,并展示了其在透析患者中的适用性。此外,总结了一种用于通过分析患者群体来识别数学模型参数的新统计技术,并介绍了基于模糊集控制器的尿毒症患者r-HuEPO给药控制策略。还展示了从模拟中获得的一些结果。

相似文献

1
Mathematical modeling of erythropoietin therapy in uremic anemia. Does it improve cost-effectiveness?尿毒症性贫血中促红细胞生成素治疗的数学模型。它能提高成本效益吗?
Haematologica. 1994 Mar-Apr;79(2):154-64.
2
Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.重组人促红细胞生成素治疗:获得性免疫缺陷综合征贫血的研究性新药方案。总体结果。
Arch Intern Med. 1993 Dec 13;153(23):2669-75.
3
Cost-effectiveness of recombinant human erythropoietin versus transfusions in the treatment of zidovudine-related anemia in HIV-infected children.重组人促红细胞生成素与输血治疗HIV感染儿童齐多夫定相关贫血的成本效益分析
Pediatr AIDS HIV Infect. 1997 Feb;8(1):4-11.
4
Does anemia correction by rHuEPO improve uremic cardiopathy?
Kidney Int Suppl. 1993 Jun;41:S70-1.
5
Drug delivery optimization through Bayesian networks.通过贝叶斯网络优化药物递送
Proc Annu Symp Comput Appl Med Care. 1992:572-8.
6
Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancer.重组人促红细胞生成素用于治疗晚期癌症患者的贫血
Semin Hematol. 1993 Oct;30(4 Suppl 6):12-6.
7
Importance of iron status monitoring during erythropoietin treatment in uremic predialysis patients.尿毒症透析前患者促红细胞生成素治疗期间铁状态监测的重要性。
Ann Univ Mariae Curie Sklodowska Med. 1994;48 Suppl 3:17-21.
8
[Recombinant human erythropoietin in the treatment of anemic patients undergoing chemotherapy for cancer].重组人促红细胞生成素用于癌症化疗贫血患者的治疗
Orv Hetil. 1995 Nov 19;136(47):2567-72.
9
Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
Semin Hematol. 1993 Oct;30(4 Suppl 6):25-7.
10
Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.重组人促红细胞生成素在治疗犬猫肾衰竭所致贫血中的应用。
J Am Vet Med Assoc. 1998 Feb 15;212(4):521-8.

引用本文的文献

1
Multi-head self-attention mechanism enabled individualized hemoglobin prediction and treatment recommendation systems in anemia management for hemodialysis patients.多头自注意力机制助力于为血液透析患者的贫血管理建立个性化血红蛋白预测及治疗推荐系统。
Heliyon. 2023 Feb 1;9(2):e12613. doi: 10.1016/j.heliyon.2022.e12613. eCollection 2023 Feb.
2
Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.在一大群血液透析患者中,达贝泊汀和铁剂治疗长期血红蛋白反应预测模型的性能。
PLoS One. 2016 Mar 3;11(3):e0148938. doi: 10.1371/journal.pone.0148938. eCollection 2016.
3
Simplification of an erythropoiesis model for design of anemia management protocols in end stage renal disease.
用于终末期肾病贫血管理方案设计的红细胞生成模型简化
Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:83-6. doi: 10.1109/IEMBS.2011.6089902.
4
Predictive modeling for improved anemia management in dialysis patients.预测模型可改善透析患者的贫血管理。
Curr Opin Nephrol Hypertens. 2011 Nov;20(6):573-6. doi: 10.1097/MNH.0b013e32834bba4e.
5
Would artificial neural networks implemented in clinical wards help nephrologists in predicting epoetin responsiveness?在临床病房中应用人工神经网络会帮助肾病学家预测促红细胞生成素的反应性吗?
BMC Nephrol. 2006 Sep 18;7:13. doi: 10.1186/1471-2369-7-13.